Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.
An abstract is available from the original source but is not redistributed by this database. Read the source record.
An abstract is available from the original source but is not redistributed by this database. Read the source record.
Selected source-checked relationships. Keep these records separate, but do not count each report as an independent study or add their participant totals.
The primary report and 12-month follow-up describe the same trial cohort. Follow-up does not provide a new randomized comparison. Checked 2026-11-03.
Registry identity: NCT03181529.
Coverage is incomplete. Missing links do not establish independence. Relationship data and source evidence (JSON).
The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.
Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.
Machine-readable provenanceThese labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.
0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.
No close related records were found yet.